Laurin S. Waldmann
About Laurin S. Waldmann
Laurin S. Waldmann is the Manager of Access & Payer Strategy at Bristol Myers Squibb, with a background in medical and pharmaceutical research.
Title
Laurin S. Waldmann holds the position of Manager, Access & Payer Strategy at Bristol Myers Squibb. In this role, he is responsible for developing and implementing strategies to optimize market access and payer negotiations. His work contributes to ensuring that patients have access to the medications they need.
Current Company
Laurin S. Waldmann is currently employed at Bristol Myers Squibb, a global biopharmaceutical company known for its innovations in medical treatments and commitment to patient care. Since assuming his role as Manager, Access & Payer Strategy, he has been involved in crafting strategies that enhance the company’s market presence and payer relations.
Education and Expertise
Laurin S. Waldmann's educational background includes a Master’s thesis completed at Harvard Medical School in 2019, and leadership studies at Stiftung Bayerische EliteAkademie, where he received an Honours Certificate. He also studied Molecular Medicine at Nanyang Technological University during a semester abroad and earned both a B.S. and M.S. in Molecular Biotechnology from Technische Universität München.
Professional Background
Laurin S. Waldmann has accumulated diverse professional experiences. He worked as a Medical Trainee at Bristol Myers Squibb in a rotational program within Munich and London from 2020 to 2022. Additionally, he served as a research fellow at the Deutscher Bundestag and Klinikum rechts der Isar der TU München. Prior roles include working student positions at goetzpartners and research internships at Boehringer Ingelheim and Helmholtz Zentrum München.